title: Antioxidant effects of a supplemented very low protein diet in chronic renal failure.
abstract: Increased peroxidation of lipids in red blood cells (RBC) in patients with advanced chronic renal failure (CRF) reflects increased generation of reactive oxygen species (ROS), which may contribute to the metabolic damage induced by CRF and to its progression. We have evaluated parameters indicative of lipoperoxidation (LPO) of RBC at baseline in patients with CRF compared to controls, and the effects of a very low protein diet supplemented with amino and keto acids and vitamins A, C, E (VLPD) over a 6-month period. The presence of peroxidation damage in CRF patients before the administration VLPD was demonstrated by elevated levels of free malondialdehyde (MDA) (p < .0003) and decreased levels of polyunsaturated fatty acids (PUFA), particularly C20:4 (p < .001), C22:4 (p < .0001) and C22:5 (p < .0001) when compared to controls. Similarly, RBC vitamin E content was significantly decreased (p < .0001) while enzymatic activities were unalterated. VLPD reduced erythrocyte LPO as suggested by (a) decreased levels of free and total RBC MDA (p < .003 and p < .03, respectively), (b) increased levels of PUFA, particularly C22:4 and C22:5 (p < .003 and p < .03, respectively), and (c) increased levels of vitamins A and E (p < .001 and p < .04, respectively) as compared to prediet results. Antioxidant enzyme activities were not modified. These results suggest that VLPD has a protective role against LPO of erythrocytes in patients with CRF.
authors.affiliation: Laboratoire de Biochime, Université de Bordeaux II, France.
authors.forename: E
authors.initials: E
authors.lastname: Peuchant
authors.forename: M C
authors.initials: MC
authors.lastname: Delmas-Beauvieux
authors.forename: L
authors.initials: L
authors.lastname: Dubourg
authors.forename: M J
authors.initials: MJ
authors.lastname: Thomas
authors.forename: A
authors.initials: A
authors.lastname: Perromat
authors.forename: M
authors.initials: M
authors.lastname: Aparicio
authors.forename: M
authors.initials: M
authors.lastname: Clerc
authors.forename: C
authors.initials: C
authors.lastname: Combe
mesh_terms: D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000494:pharmacology*; D002374:Catalase / Q000097:blood; D004044:Dietary Proteins / Q000008:administration & dosage*; D004912:Erythrocytes / Q000201:enzymology / Q000378:metabolism*; D005231:Fatty Acids, Unsaturated / Q000097:blood; D005260:Female; D005979:Glutathione Peroxidase / Q000097:blood; D006801:Humans; D007676:Kidney Failure, Chronic / Q000178:diet therapy*; D015227:Lipid Peroxidation / Q000187:drug effects*; D008055:Lipids / Q000097:blood; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D008875:Middle Aged; D018384:Oxidative Stress / Q000187:drug effects*; D013482:Superoxide Dismutase / Q000097:blood; D014801:Vitamin A / Q000097:blood; D014810:Vitamin E / Q000097:blood
chemical_list: D000975:Antioxidants; D004044:Dietary Proteins; D005231:Fatty Acids, Unsaturated; D008055:Lipids; D014801:Vitamin A; D014810:Vitamin E; D008315:Malondialdehyde; D002374:Catalase; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase